Joint Pain Injections Market Expansion Continues, with Forecast Valuation of $9.81 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Joint Pain Injections Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for injections to combat joint pain has witnessed a rapid expansion in recent years. The market is forecasted to spike from $5.6 billion in 2024 to $6.17 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.1%. The historic growth seen in this sector can be credited to factors like an influx in the aging population, a growing incidence of arthritis, worldwide health campaigns, digitalization within healthcare systems, and a heightened awareness in managing chronic pain.

Joint Pain Injections Market Size Forecast: What's the Projected Valuation by 2029?
The market of injections for joint pain is predicted to witness a fast-paced expansion in the coming years, reaching a value of $9.81 billion in 2029 with a compound annual growth rate (CAGR) of 12.3%. The projected growth in the forecast period is likely due to factors such as the development of telehealth services, customized pain management strategies, patient learning and empowerment, sustainable health care approaches, and nutritional support. Key trends during the estimated period consist of advances in regenerative medicine, personalized pain management, innovation in injection materials, enhancements in rehabilitation technologies, and artificial intelligence-enhanced injections.

View the full report here:
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

What Are the Drivers Transforming the Joint Pain Injections Market?
The escalation of arthritis and musculoskeletal disorders is anticipated to fuel the expansion of the joint pain injections market. Globally, musculoskeletal disorders stand as the topmost cause of disabilities, with lower back pain being the chief impairment across 160 countries. Patients opt for injections for alleviating pain and inflammation. For instance, in June 2023, as reported by the Australian Institute of Health and Welfare, a governmental agency of Australia, rheumatoid arthritis accounted for 2.0% of the entire disease burden and 16% of the total musculoskeletal disease-related burden. In 2022, it was associated with 1,322 deaths, equivalent to 5.1 deaths per 100,000 people, equalling 0.7% of all deaths. Thus, the growing occurrence of arthritis and musculoskeletal disorders propels the joint pain injections market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

What Long-Term Trends Will Define the Future of the Joint Pain Injections Market?
Leading businesses in the joint pain injection domain are honing in on innovative strategies, such as one-time injection solutions, offering greater patient ease. One-time injection solutions are a type of drug delivery system engineered to deliver a fixed dosage of medicine in one shot, yielding prolonged therapeutic results without requiring numerous doses. For instance, LG Chem Ltd., a chemical company from South Korea, introduced Synovian in China in July 2024, a groundbreaking treatment for knee osteoarthritis that involves a manageable one-time injection, a first of its kind in the region. This product is set to penetrate a substantial market approximately valued at KRW 200 billion (around USD 150 million). Made using unique technology, it demonstrates inventive approaches to meeting patient necessities. The primary concern is to offer effective relief with reduced administration barriers.

Which Segments in the Joint Pain Injections Market Offer the Most Profit Potential?
The joint pain injections market covered in this report is segmented -

1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of Injections
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Steroid Joint Injection: Corticosteroid Injections, Combination Steroid Injections
2) By Hyaluronic Acid Injections: Single-Dose Hyaluronic Acid Injections, Multi-Dose Hyaluronic Acid Injections
3) By Platelet-Rich Plasma (PRP) Injections: Autologous PRP Injections, Allogeneic PRP Injections
4) By Placental Tissue Matrix (PTM) Injections: Amniotic Fluid Injections, Placental Derived Cell Injections
5) By Other Types of Injections: Bone Marrow Aspirate Concentrate (BMAC) Injections, Stem Cell Injections, Genetically Engineered Cell Injections

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6482&type=smp

Which Firms Dominate the Joint Pain Injections Market by Market Share and Revenue in 2025?
Major companies operating in the joint pain injections market include Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet Holdings Inc., Sanofi S.A., Anika Therapeutics Inc., Abbvie Inc., Bioventus Inc., Eli Lilly and Company, Ferring Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Johnson & Johnson Services Ltd., Merck & Co. Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc, Roche Holding AG, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Bayer AG, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen SA, Mallinckrodt Pharmaceuticals Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Zydus Lifesciences Limited

Which Regions Offer the Highest Growth Potential in the Joint Pain Injections Market?
North America was the largest region in the joint pain injections market in 2024. The regions covered in the joint pain injections market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6482

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.